Product Description
| Brand |
Medtronic |
| Stent Diameter (mm) |
3.50 |
| Stent Length (mm) |
09, 12, 18 & 34, |
| CAT No |
RSINT35009X, RSINT35012X, RSINT35018X & RSINT35034X |
| Catheter Length |
300 cm |
Resolute Integrity is a drug-eluting stent (DES) and balloon catheter that offers excellent deliverability and flexibility for percutaneous coronary interventions.
Next-Generation Drug-Eluting TechnologyThe Resolute Integrity DES utilizes Medtronic's exclusive BioLinx polymer system for controlled zotarolimus elution, enhancing biocompatibility and minimizing risk of restenosis. Its proven drug delivery mechanism offers confidence in long-term vessel patency, making it ideal for coronary artery disease interventions where efficacy is essential.
Superior Flexibility and DeliverabilityWith high flexibility from its continuous sinusoid strut design and an ultra-lightweight cobalt chromium alloy, this stent is expertly engineered to navigate even the most challenging, tight, or tortuous lesions. Enhanced crossability and excellent radiopacity simplify accurate positioning during percutaneous coronary interventions.
Safe, Reliable, and User-FriendlyDesigned for single use and supplied sterile, the Resolute Integrity stent ensures patient safety and minimizes infection risk. It is MR conditional for safe imaging under specified conditions, and features a manual, rapid exchange delivery system for ease of use by interventional cardiologists.
FAQ's of Medtronic Resolute Integrity DES Drug-eluting Stent (SD 3.50):
Q: How does the Medtronic Resolute Integrity DES (SD 3.50) work to treat coronary artery disease?
A: The stent re-opens and supports narrowed or blocked coronary arteries. It slowly releases zotarolimus, a drug that helps prevent restenosis (re-narrowing), using the proprietary BioLinx biocompatible polymer, ensuring a reduced risk of future arterial blockages.
Q: What advantages does the continuous sinusoid design offer in this drug-eluting stent?
A: The continuous sinusoid architecture provides enhanced flexibility and deliverability, making it easier to navigate and position the stent within tight or tortuous coronary lesions for more precise and reliable placement.
Q: When is this stent typically used and what is its main clinical indication?
A: The Resolute Integrity DES (SD 3.50) is indicated for percutaneous coronary intervention (PCI), a procedure performed to treat patients with coronary artery disease who have significant arterial blockages requiring stent placement.
Q: Where should the Medtronic Resolute Integrity DES be stored before use?
A: It should be kept sterile in its original packaging at room temperature, away from moisture, until the expiration date specified on the label, to maintain its safety and effectiveness.
Q: What is the process for implanting this drug-eluting stent?
A: A physician manually delivers the stent using the rapid exchange catheter system during PCI. Radiopaque markers assist in accurate placement before the stent is expanded to support the artery wall and release zotarolimus.
Q: Is the stent MRI safe after implantation?
A: Yes, the Resolute Integrity DES is MR conditional, meaning it can be safely scanned under specific MRI conditions as provided in the Instructions for Use (IFU).
Q: What benefits can patients expect from this stent compared to conventional stents?
A: Patients benefit from reduced risk of restenosis, high flexibility for challenging lesions, excellent placement accuracy, and safer MRI compatibility, resulting in improved outcomes for coronary artery disease treatment.